US: ABMC - Amer Bio Medica

Rentabilität für sechs Monate: 0%
Dividendenrendite: 0.00%

Aktionsplan Amer Bio Medica


Über das Unternehmen Amer Bio Medica

American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs.

weitere details
The company also offers a test for the detection of respiratory syncytial virus; OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases. Further, it provides strip contract manufacturing, assembly, and packaging services to unaffiliated diagnostic companies. The company serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets. It operates in the United States, North America, Europe, the Asia Pacific, and South America. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York.

IPO date 1997-12-24
ISIN US0246001087
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.abmc.com
Цена ао 0.0002
Preisänderung pro Tag: 0% (0.0001)
Preisänderung pro Woche: 0% (0.0001)
Preisänderung pro Monat: 0% (0.0001)
Preisänderung über 3 Monate: -50% (0.0002)
Preisänderung über sechs Monate: 0% (0.0001)
Preisänderung pro Jahr: -50% (0.0002)
Preisänderung über 3 Jahre: -99.75% (0.04)
Preisänderung über 5 Jahre: -99.88% (0.0805)
Preisänderung über 10 Jahre: 0% (0.0001)
Preisänderung seit Jahresbeginn: 0% (0.0001)

Unterschätzung

Name Bedeutung Grad
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Gesamt: 2.5

Effizienz

Name Bedeutung Grad
ROA, % 0 0
ROE, % 0 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % -76.42 0
Rentabilität Ebitda, % 70.78 8
Rentabilität EPS, % -224.52 0
Gesamt: 4.6

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Ms. Jean Neff Corporate Secretary & Independent Director 1943 (82 Jahr)
Mr. J. Duncan Urquhart Controller 1954 (71 Jahr)

Adresse: United States, Kinderhook, 122 Smith Road - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.abmc.com